Semi-Annual Consolidated Balance Sheet

Solasia Pharma K.K. - Filing #7272454

Concept As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Semi-annual consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
875,000,000 JPY
719,000,000 JPY
Other
42,000,000 JPY
78,000,000 JPY
Current assets
1,249,000,000 JPY
957,000,000 JPY
Non-current assets
Property, plant and equipment
20,000,000 JPY
22,000,000 JPY
Property, plant and equipment
Leased assets
Leased assets, net
1,000,000 JPY
0 JPY
Investments and other assets
87,000,000 JPY
87,000,000 JPY
Investments and other assets
Non-current assets
107,000,000 JPY
109,000,000 JPY
Assets
1,356,000,000 JPY
1,066,000,000 JPY
Liabilities
Current liabilities
Income taxes payable
16,000,000 JPY
10,000,000 JPY
Current liabilities
281,000,000 JPY
350,000,000 JPY
Non-current liabilities
Other
12,000,000 JPY
13,000,000 JPY
Non-current liabilities
40,000,000 JPY
43,000,000 JPY
Liabilities
321,000,000 JPY
394,000,000 JPY
Net assets
Shareholders' equity
Share capital
2,211,000,000 JPY
1,596,000,000 JPY
Capital surplus
2,522,000,000 JPY
1,907,000,000 JPY
Retained earnings
-3,633,000,000 JPY
-2,764,000,000 JPY
Treasury shares
-65,000,000 JPY
-69,000,000 JPY
Shareholders' equity
1,035,000,000 JPY
670,000,000 JPY
Share acquisition rights
JPY
1,000,000 JPY
Net assets
JPY
-3,633,000,000 JPY
2,522,000,000 JPY
1,035,000,000 JPY
2,211,000,000 JPY
-65,000,000 JPY
1,035,000,000 JPY
1,000,000 JPY
1,596,000,000 JPY
672,000,000 JPY
-2,764,000,000 JPY
670,000,000 JPY
1,907,000,000 JPY
-69,000,000 JPY
-70,000,000 JPY
1,031,000,000 JPY
1,746,000,000 JPY
1,027,000,000 JPY
1,436,000,000 JPY
-2,084,000,000 JPY
3,000,000 JPY
Liabilities and net assets
1,356,000,000 JPY
1,066,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.